Top

Diabetologia

Content (35 Articles)

The insulin signalling system and the IRS proteins

M. F. White

Control of PHAS-I phosphorylation in 3T3-L1 adipocytes: effects of inhibiting protein phosphatases and the p70S6K signalling pathway

T.-A. Lin, J. C. Lawrence Jr.

Mitogenic properties of insulin and insulin analogues mediated by the insulin receptor

D. Ish-Shalom, C. T. Christoffersen, P. Vorwerk, N. Sacerdoti-Sierra, R. M. Shymko, D. Naor, P. De Meyts

Signal transduction mechanisms in nutrient-induced insulin secretion

M. Prentki, K. Tornheim, B. E. Corkey

Engineered cell lines for insulin replacement in diabetes: current status and future prospects

C. B. Newgard, S. Clark, H. BeltrandelRio, H. E. Hohmeier, C. Quaade, K. Normington

The new era of biotech insulin analogues

J. Brange

Modifications in the B10 and B26–30 regions of the B chain of human insulin alter affinity for the human IGF-I receptor more than for the insulin receptor

L. J. Slieker, G. S. Brooke, R. D. DiMarchi, D. B. Flora, L. K. Green, J. A. Hoffmann, H. B. Long, L. Fan, J. E. Shields, K. L. Sundell, P. L. Surface, R. E. Chance

Hypoglycaemia in diabetes mellitus – protecting the brain

S. A. Amiel

Alteration in brain glucose metabolism induced by hypoglycaemia in man

P. J. Boyle

Intensive insulin therapy in clinical practice

P. D. Home

Microdialysis techniques in the study of brain and skeletal muscle

D. G. Maggs, W. P. Borg, R. S. Sherwin

Are presently available insulin analogues clinically beneficial?

M. Berger, L. Heinemann

Translating the Diabetes Control and Complications Trial (DCCT) into clinical practice: overcoming the barriers

B. Zinman

Alternative insulin delivery systems: how demanding should the patient be?

K. S. Polonsky, M. M. Byrne, J. Sturis

Advances and prospects in glucose assay technology

D. A. Gough, J. C. Armour, D. A. Baker

The pathogenesis of atherosclerosis

R. G. Gerrity, A. S. Antonov

Inflammation in the vascular wall as an early event in atherosclerosis

S. M. Prescott, G. A. Zimmerman, T. M. McIntyre, D. M. Stafforini

Endothelial control of vascular tone in diabetes mellitus

L. Poston

Cytosolic NADH/NAD+ , free radicals, and vascular dysfunction in early diabetes mellitus

Y. Ido, C. Kilo, J. R. Williamson

Factors regulating the expression of vascular permeability/vascular endothelial growth factor by human vascular tissues

B. Williams

Coronary heart disease and risk factors in NIDDM – experience from the United Kingdom Prospective Diabetes Study

R. C. Turner, H. Millns, R. R. Holman

Predictors of coronary heart disease and death in NIDDM: The Diabetes Intervention Study experience

M. Hanefeld, H. Schmechel, U. Schwanebeck, J. Lindner

Influence of diabetes mellitus on the heart and macrovascular mortality

E. Standl, O. Schnell, B. Balletshofer, E. Schleicher, D. Muhr, A. G. Ziegler, M. Haslbeck

Microvascular heart disease in diabetes mellitus

J. Goodfellow

Antihypertensive treatment and mortality in diabetic patients What is the evidence?

P. T. Sawicki, T. Heise, M. Berger

Impaired glucose tolerance – is it relevant for cardiovascular disease?

S. M. Haffner

Insulin resistance due to hyperglycaemia: an adaptation protecting insulin-sensitive tissues

H. Yki-Järvinen, S. Mäkimattila

Diabetes mellitus, dyslipoproteinaemias and atherosclerosis

G. Steiner

LDL heterogeneity: implications for atherogenicity in insulin resistance and NIDDM

D. J. Betteridge

The pathogenetic role of impaired fatty acid trapping by adipocytes in generating the pleiotropic features of hyperapoB

A. D. Sniderman, K. Cianflone, K. Frayn

Molecular basis and promise of genetic therapy for diabetic dyslipidaemia: studies in an animal model of diabetes

L. Chan, K. Kobayashi

Pharmacological reversal of advanced glycation end-product-mediated protein crosslinking

P. Ulrich, X. Zhang

Cardiovascular effects of sulphonylurea derivatives

P. Smits

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.